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and Saeideh Karimi Haghighi, BS, MS‡AbstractSigniﬁcance
The administration of a buccal inﬁltration injection
of 0.7mL8.4%sodiumbicarbonate before an infe-
rior alveolar nerve block injection can be helpful for
clinicians to improve the efﬁcacy of the anesthesia
in mandibular ﬁrst molars with symptomatic irre-
versible pulpitis.Introduction: The purpose of this prospective, random-
ized, double-blind study was to evaluate the effect of a
buccal infiltration of sodium bicarbonate on the anes-
thetic success of the inferior alveolar nerve block
(IANB) for mandibular first molars in patients with symp-
tomatic irreversible pulpitis.Methods: One hundred pa-
tients diagnosed with symptomatic irreversible pulpitis
of a mandibular first molar were selected. The patients
randomly received a buccal infiltration injection of either
0.7 mL 8.4% sodium bicarbonate with 0.3 mL 2% lido-
caine containing 1:80,000 epinephrine or 0.7 mL sterile
distilled water with 0.3 mL 2% lidocaine containing
1:80,000 epinephrine in a double-blind manner. After
15 minutes, all the patients received conventional
IANB injection using 3.6 mL 2% lidocaine with
1:80,000 epinephrine. Access cavity preparation was
initiated 15 minutes after the IANB injection. Lip numb-
ness was a requisite for all the patients. Success was
determined as no or mild pain on the basis of Heft-
Parker visual analog scale recordings upon access cavity
preparation or initial instrumentation. Data were
analyzed using the t, chi-square and Mann-Whitney U
tests. Results: The success rate after the buccal infiltra-
tion of sodium bicarbonate was 78%, whereas without
the buccal infiltration of sodium bicarbonate it was 44%
(P < .001). Conclusions: A buccal infiltration of 0.7 mL
8.4% sodium bicarbonate increased the success rate of
IANBs in mandibular first molars with symptomatic irre-
versible pulpitis. (J Endod 2016;42:1458–1461)From the *Dental Research Center, †Department of Endodonti
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anesthesia, transient receptor potential vanilloid receptor type 1The inferior alveolarnerve block (IANB) is
the most routine tech-
nique used to anesthetize
mandibular molars for
endodontic treatment
(1, 2). However, the
success rate is not always
adequate to ensure
profound pulpal anesthesia, particularly in patients with irreversible pulpitis (3, 4).
The most likely explanation for the decrease in efficacy of local anesthesia in in-
flamed pulp can be the activation effect of inflammation on the peripheral free terminals
of nociceptive neurons and associated central mechanisms (5–9). During
inflammation, protons (hydrogen ions) are among the first mediators released by
damaged cells, inducing a local pH fall (10, 11). The lowering pH plays a dominant
role in the inflammatory activation and sensitization of nociceptive neurons
(11–13). This is caused by activation of different ionic channels such as acid-
sensing ion channels (ASICs) (11), transient receptor potential channels (8, 11),
and tetrodotoxin-resistant sodium channels (14) (Fig. 1). Therefore, it is hypothesized
that buccal infiltration of an alkalizing agent will reduce nociceptor activation by
increasing the pH of the inflamed tissue and will result in improved efficacy of local
anesthesia in patients with symptomatic irreversible pulpitis.
Sodium bicarbonate is an alkalinizing agent that is commonly used for the treat-
ment of metabolic acidosis. It also has been used for buffering of local anesthetics. Some
studies have shown that increasing the pH of a local anesthetic solution by adding so-
dium bicarbonate reduces the pain of injection (15–18), accelerates the onset of
anesthesia (15, 17, 18), and improves the efficacy of anesthesia (18–20). Others
have reported that adding sodium bicarbonate to local anesthetic solutions cannot
reduce the pain of injection (21–23), accelerate the onset of anesthesia (22, 23), orcs, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran; and ‡Neuroscience
ehran, Iran.
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Figure 1. The activation effect of acidic extracellular pH on the ion channel
receptors. ASICs, acid-sensing ion channels; TRPV1, transient receptor poten-
tial vanilloid 1 channel; TTX-Rs, tetrodotoxin-resistant sodium channels.
Clinical Researchimprove the efficacy of anesthesia (23, 24). Two recent studies have
reported that adding sodium bicarbonate to lidocaine cannot
improve the efficacy of IANBs in patients with irreversible pulpitis
(25, 26).
There are no studies on the use of buccal infiltration injection of an
alkalizing agent for IANBs in teeth with irreversible pulpitis. The pur-
pose of this prospective, randomized, double-blind study was to eval-
uate the effect of a buccal infiltration injection of 0.7 mL 8.4%
sodium bicarbonate on the success rate of IANBs for mandibular first
molars in patients with symptomatic irreversible pulpitis.
Materials and Methods
One hundred healthy adult patients participated in this study. They
were emergency patients of the clinic of the endodontic department of
Isfahan University of Medical Sciences, Isfahan, Iran. We excluded po-
tential patients who were under 18 years of age, had a history of signif-
icant medical conditions, were pregnant, were allergic to local
anesthetics or sulfites, were taking any medications that might influence
anesthetic assessment, had active sites of pathosis in the area of injec-
tion, and were unable to give informed consent. The ethics committee of
the university approved the protocol of the study (no. 3941020,
ClinicalTrials.gov number, NCT02726737). Written informed consent
was obtained from all the patients. To qualify for inclusion in the study,
each patient had a vital mandibular first molar with active moderate to
severe pain and had a prolonged response to cold testing with cold
spray (Endo-Frost; Coltene-Whaledent, Langenau, Germany). Patients
with no response to cold testing, no vital coronal pulp tissue on access,
or a periapical lesion (other than widening of the periodontal ligament
space) were not included in the study. Therefore, each patient had a
vital mandibular first molar with a clinical diagnosis of symptomatic
irreversible pulpitis.
Each patient rated his or her initial pain on a Heft-Parker visual
analog scale (HP-VAS) (27). This scale is a 170-mm marked line
that is divided into 4 categories with various terms describing the level
of pain. No pain, mild pain, moderate pain, and severe pain were indi-
cated by 0 mm, 1- to 54-mm, 55- to 113- mm, and 114- to 170-mm
divisions, respectively. Patients exhibiting moderate to severe initial
pain were included in the study.
For the sodium bicarbonate group, 0.7 mL 8.4% sodium bicar-
bonate (Caspian Tamin Pharmaceutical Co, Rasht, Iran) was drawn
with a sterile microliter syringe (Hamilton, Bonaduz, Switzerland) fittedJOE — Volume 42, Number 10, October 2016with a disposable 27-G needle. Then, 0.3 mL 2% lidocaine with
1:80,000 epinephrine (Lignospan; Septodont, Saint Maur des Fosses,
France) was drawn with the same syringe. Therefore, the sodium bicar-
bonate solution contained 0.7mL 8.4% sodium bicarbonate and 0.3 mL
2% lidocaine. The syringe was inverted 5 times to mix the solution, and
no precipitation was observed. For the non–sodium bicarbonate group,
0.7 mL sterile distilled water was drawn with the Hamilton syringe.
Then, 0.3 mL 2% lidocaine with 1:80,000 epinephrine was added in
the same way. Therefore, the non–sodium bicarbonate solution con-
tained 0.7 mL sterile distilled water and 0.3 mL 2% lidocaine. A trained
dental assistant prepared the solutions just before the injections and
coded them in a random manner. One operator administered buccal
infiltration injections of either sodium bicarbonate or non–sodium bi-
carbonate solution for each patient. The operator and patients were
both blinded to the contents of the solution.
Before each buccal infiltration, the mucosa was dried, and 20%
benzocaine gel (Ultradent Products Inc, South Jordan, UT) was applied
to the injection site for 60 seconds. The intended target site was centered
over the buccal root apices of the mandibular first molar to be treated.
The 27-G needle was placed into the alveolar mucosa and advanced until
the needle was estimated to be at or just superior to the apices of the
tooth. The solution was deposited over a period of 1 minute.
After 15 minutes, the same operator administered 2 standard
IANBs (1.8-mL cartridges) of 2% lidocaine with 1:80,000 epinephrine
(Lignospan; Septodont, Saint Maur des Fosses, France) for each patient.
All the injections were performed using a standard aspirating dental in-
jection syringe and a 27-G, 31-mm needle (CK ject; CK Dental, Kor-
Kyungji-do, Korea). Lip numbness was considered as a criterion for
IANB achievement; the patient was questioned for lip numbness 15 mi-
nutes after the injection. If lip numbness was not achieved, the IANB was
indicated as missed, and the patient was excluded from the study. No
patient was excluded from the study as a result of a lack of lip numbness.
Fifteen minutes after the injection, the teeth were isolated with a rubber
dam, and access cavities were prepared.
The same operator instructed the patients to rate any pain felt dur-
ing access cavity preparation or the initial file placement. If the patient
felt pain, the treatment was immediately ceased, and the patient rated the
pain level by using the HP-VAS. The success of the IANB was defined as
no pain or mild pain (HP-VAS score#54).
Statistical Analysis
Data on age, sex, initial pain, and the success of IANB ratings were
statistically analyzed using SPSS software version 20 (IBM Corporation,
Armonk, NY). Comparisons between the sodium bicarbonate and non–
sodium bicarbonate groups for the success of the IANB and sex differ-
ences were analyzed using the chi-square test, age was analyzed using
the t test, and initial pain was analyzed using the Mann-Whitney U
test. With a 2-sided alpha risk of 0.05, a sample size of 50 subjects
per group was required to detect a difference of30 percentage points
in anesthetic success with a power of more than 0.80. Statistical signif-
icance was defined as P < .05.
Results
One hundred adult patients, 27 men and 73 women, with an age
range of 18–53 years and a mean of 29  9 years, participated in the
study. Baseline variables for the sodium bicarbonate and non–sodium
bicarbonate groups are presented in Table 1. There were no significant
differences in age, sex, or initial pain between the 2 groups (P > .05).
The IANB success rate was 78% for the sodium bicarbonate group and
44% for the non–sodium bicarbonate group. There was a statistically
significant difference in success rates between the 2 groups (P < .001).Sodium Bicarbonate Buccal Infiltration 1459
TABLE 1. Baseline Variables for the Sodium Bicarbonate and Non–Sodium
Bicarbonate Groups
Variable
Sodium
bicarbonate
Non–sodium
bicarbonate
P
value†
Total subjects 50 50
Age (y) 18–53 18–43 .733
Sex .822
Female 37 36
Male 13 14
Initial pain* 107 (28.6) 113 (30.0) .352
*Mean (standard deviation).
†There were no significant differences between the 2 groups (P > .05).
Clinical ResearchDiscussion
The results of this study indicated that a buccal infiltration of so-
dium bicarbonate 15 minutes before endodontic treatment significantly
improves the efficacy of IANBs for first mandibular molar teeth with
symptomatic irreversible pulpitis. Baseline variables of patients (age,
sex, and initial pain) were not significantly different between the 2
groups. Therefore, these variables had no effect on the results
(Table 1). All the teeth had a long response to cold testing and exhibited
vital coronal pulp tissue on access preparation with moderate to severe
initial pain, which indicated that the teeth had symptomatic irreversible
pulpitis.
In the present study, only mandibular first molars were included
because second and third molars have a thicker cortical plate and may
prevent the solution from penetrating around the apical foramen.
Before the study, to determine the patient’s tolerance for a supraperios-
teal buccal infiltration of 0.7 mL 8.4% sodium bicarbonate and 0.7 mL
sterile distilled water, the first author performed each of the 2 injections
twice on himself and reported severe and moderate transient pain after
the injection of sodium bicarbonate and sterile distilled water, respec-
tively. To solve this problem, 0.3 mL 2% lidocaine with 1:80,000
epinephrine was added to each infiltration solution. Moreover, a topical
anesthetic gel was applied before each injection. In this study, patients
had no significant pain after the buccal infiltration injections and also no
significant lip numbness before the IANB injections.
In this study, the efficacy of IANB was assessed by measuring the
pain level during access cavity preparation and initial instrumentation
using HP-VAS, and additional tests with an electric pulp tester were
omitted. This was based on the results of Nusstein et al (28) in which
an electric pulp tester was used for measuring the pain level for teeth
with irreversible pulpitis. They reported that after receiving anesthesia,
42% of patients with a negative response to electric pulp testing still re-
ported pain during treatment and needed supplemental injections.
The evidence suggests that the activation of nociceptors by inflam-
matory mediators is a major cause for a decrease in the success rate of
local anesthesia in patients with irreversible pulpitis (5–9). Some
studies used a buccal infiltration injection of ketorolac, a
nonsteroidal anti-inflammatory drug (29, 30), or dexamethasone, a
steroidal drug (31), to reduce tissue inflammation and nociceptor acti-
vation to improve the efficacy of IANB for teeth with irreversible pulpitis.
Moreover, there is a strong interaction between inflammatorymediators
and tissue acidosis in terms of prevalence and magnitude of nociceptor
activation (12, 32). The algogenic effects of tissue acidosis are caused
by the depolarization of nociceptive neurons through activation of
different ion channels (11). ASICs are membrane protein complexes
with 6 subunits (33). Some of them are able to be activated by very small
acidification from a physiological pH of 7.4 to 7.2 and generate a sus-
tained depolarizing current (11). Among transient receptor potential
channels, the role of transient receptor potential vanilloid receptor1460 Saatchi et al.type 1 (TRPV1) channels is more prominent, and they are expressed
predominantly by nociceptors. TRPV1 responds to a pH value below
6. However, mild acidosis in the pH range of 6 to 7 can sensitize the
channel to other stimuli such as capsaicin and heat (6, 8, 33).
Tetrodotoxin-resistant sodium channels Nav 1.8 and Nav 1.9 are also
influenced by tissue acidosis. Local acidosis (weak
acid$ pH = 6.0) prepares them to be suitable for the repetitive acti-
vation even at depolarized membrane potentials (14). Furthermore, in
relation to the role of acid signaling in pain associated with the trigem-
inal sensory system, evidence has shown that ASIC3 and TRPV1 are ex-
pressed in trigeminal ganglia (10, 34, 35). Therefore, tissue acidosis
might have a role in the failure of IANB anesthesia in patients with
irreversible pulpitis. Further studies on this issue are desirable.
In conclusion, a buccal infiltration of 0.7 mL 8.4% sodium bicar-
bonate improved the efficacy of IANB for mandibular first molars in pa-
tients with symptomatic irreversible pulpitis.
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